Close log in window
Terry Slavin, (Dec 20, 2017)
The Boston Consulting Group’s Douglas Beal explains the consultancy’s research showing that companies that put ‘doing good’ at the heart of business strategy outperform their peers
Mark Hillsdon, (Jun 14, 2017)
With cancer and diabetes now more prevalent in poor countries than in the West, 23 companies, including Pfizer, Novartis, GlaxoSmithKline and Japan's Takeda, are developing partnerships in some of the hardest-hit regions to extend access to life-saving medicines
Claire Manuel, (Feb 27, 2017)
The Pharmaceutical Supply Chain Initiative, the Global e-Sustainability Initiative and ETI show how competitors can collaborate
EC Newsdesk, (Nov 18, 2016)
Janssen’s EMEA group chairman Jane Griffiths on the dynamic new business models that are helping society and the bottom line
Robert Lock, (Nov 18, 2016)
The US pharma giant’s straight-talking report makes its prescription for a better world easier for investors to swallow
April Streeter, (Nov 6, 2014)
The healthcare industry is often seen as being in the pocket of pharmaceutical giants. But some say this closeness is beneficial, and excessive transparency could be damaging